FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival

ABSTRACT Background FXYD3 is a Na/K‐ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo‐naive patients with surgically‐resected PDAC at a single centre (1993–2014). Method FXYD3 expressio...

Full description

Bibliographic Details
Published in:Cancer Medicine
Main Authors: Nathalie B. Rasko, Christopher B. Nahm, John Turchini, Rachel Teh, Helge Rasmussen, Sooin Byeon, Sumit Sahni, Jaswinder S. Samra, Anthony J. Gill, Anubhav Mittal
Format: Article
Language:English
Published: Wiley 2025-01-01
Subjects:
FXYD3
MAT‐8
pancreatic cancer
pancreatic ductal adenocarcinoma
prognosis
survival
Online Access:https://doi.org/10.1002/cam4.70500

Internet

https://doi.org/10.1002/cam4.70500

Similar Items